Diagnóstico
-
AutoDELFIA®RevvityAutoDELFIA® immunoassay system for prenatal screening is supported by the widest available range of prenatal analytes available on any platform. Reliable and easy to use AutoDELFIA instrument offers high quality results both for aneuploidy and pre-eclampsia risk assessment during pregnancy. -
GSP® InstrumentRevvityThe instrument is fully automated, performing every stage of an assay from retrieval of the sample plate from the stacker to measurement and reporting of results. Genetic Screening Processor utilizes specific GSP Workstation software for handling of the newborn screening data. -
Newborn ScreeningRevvityUse the highest quality reagents available today to screen for core newborn disorders as well as those detected by expanded screening. Our reagents are the industry standard for analytical performance and reliability in detecting congenital diseases that are treatable only when identified during the first days of life. -
Vanadis NIPT systemRevvityBased on a breakthrough in advanced genetic analytics, Vanadis® NIPT system is the only NIPT screening platform to enable targeted cfDNA analysis without next-generation sequencing or PCR, instead directly capturing target fragments and labeling them for counting. A proprietary nanofilter plate then captures labeled molecules for imaging, eliminating the need for data-intensive steps such as DNA sequencing, microarrays, and microfluidics. -
Pre-Eclampsia Screening and Prenatal ImmunoassaysRevvityPerkinElmer offers a comprehensive range of prenatal and pre-eclampsia assays with high analytical sensitivity of the DELFIA® chemistry. The samples can be processed with three different instruments: random access, batch processing or semi-automatic. PerkinElmer offers complete systems to monitor health during pregnancy including assays, instruments and software. Get the high sensitivity of DELFIA® chemistry in our prenatal and pre-eclampsia assays.
